<p>Levels of MCP-1 (A), IL-8 (B), MMP-9 (C), sVCAM-1 (D), sICAM-1 (E) and TNF-α (F) during the first 6 weeks after inclusion (median time 22 h, interquartile range 14, 29, after PCI), (n = 61). Inset: The results according to randomization groups, levosimendan (n = 30) or placebo (n = 31). Median values with interquartile range. * Change from baseline, p<0.05 ** Change from baseline, p<0.001.</p
Background: The prognostic value of chronic inflammation markers in patients after myocardial infarc...
Course of inflammatory activation during acute myocardial infarction in patients with preserved left...
International audienceOBJECTIVES:Acute myocardial infarction (MI) leads to molecular, structural, ge...
No data from controlled trials exists regarding the inflammatory response in patients with de novo h...
ObjectivesWe sought to determine the relationship between circulating cytokine levels and clinical o...
Chronic inflammation is one of the main underlying mechanisms in the development of coronary artery ...
(1) Background: The prediction of recurrent events after acute myocardial infarction (AMI) does not ...
Acute ST-segment elevation myocardial infarction (STEMI) activates inflammation that can contribute ...
<p>Changes in wall motion score index from inclusion (median 22 h, interquartile range 14, 29 after ...
Aim: We investigated the ability of prototypical inflammatory cytokines to predict clinical outcomes...
Aim We investigated the ability of prototypical inflammatory cytokines to predict clinical outcomes...
BACKGROUND: Several cytokines are associated with the development and/or progression of chronic hear...
Aim. To evaluate the effect of biomarkers of inflammation on the long-term prognosis in patients wit...
Chronic heart failure (CHF) results in both increased cardiac sympathetic activity and myocardial in...
Objective. The aim of our study was to evaluate the clinical utility and prognostic significance of ...
Background: The prognostic value of chronic inflammation markers in patients after myocardial infarc...
Course of inflammatory activation during acute myocardial infarction in patients with preserved left...
International audienceOBJECTIVES:Acute myocardial infarction (MI) leads to molecular, structural, ge...
No data from controlled trials exists regarding the inflammatory response in patients with de novo h...
ObjectivesWe sought to determine the relationship between circulating cytokine levels and clinical o...
Chronic inflammation is one of the main underlying mechanisms in the development of coronary artery ...
(1) Background: The prediction of recurrent events after acute myocardial infarction (AMI) does not ...
Acute ST-segment elevation myocardial infarction (STEMI) activates inflammation that can contribute ...
<p>Changes in wall motion score index from inclusion (median 22 h, interquartile range 14, 29 after ...
Aim: We investigated the ability of prototypical inflammatory cytokines to predict clinical outcomes...
Aim We investigated the ability of prototypical inflammatory cytokines to predict clinical outcomes...
BACKGROUND: Several cytokines are associated with the development and/or progression of chronic hear...
Aim. To evaluate the effect of biomarkers of inflammation on the long-term prognosis in patients wit...
Chronic heart failure (CHF) results in both increased cardiac sympathetic activity and myocardial in...
Objective. The aim of our study was to evaluate the clinical utility and prognostic significance of ...
Background: The prognostic value of chronic inflammation markers in patients after myocardial infarc...
Course of inflammatory activation during acute myocardial infarction in patients with preserved left...
International audienceOBJECTIVES:Acute myocardial infarction (MI) leads to molecular, structural, ge...